Jennifer G. Pryor

IMP-3 is a novel progression marker in malignant melanoma

Jennifer G. Pryor, Patricia Bourne, Qi Yang et al. · Modern Pathology · 2008 · 81 citations · Full text

Medicine, Cancer Biology, Oncology +14

Diagnostic utility of IMP3 in segregating metastatic melanoma from benign nevi in lymph nodes

Mark J. Mentrikoski, Linglei Ma, Jennifer G. Pryor et al. · Modern Pathology · 2009 · 35 citations

Medicine, Oncology, Pathology +17

Microarray Comparative Genomic Hybridization Detection of Copy Number Changes in Desmoplastic Melanoma and Malignant Peripheral Nerve Sheath Tumor

Jennifer G. Pryor, Brigette A Brown-Kipphut, M. Anwar Iqbal et al. · American Journal of Dermatopathology · 2011 · 35 citations

Medicine, Genetics, Oncology +17

Is the Association of “Cup-like” Nuclei With Mutation of the <i>NPM1</i> Gene in Acute Myeloid Leukemia Clinically Useful?

John M. Bennett, Jennifer G. Pryor, Todd S. Laughlin et al. · American Journal of Clinical Pathology · 2010 · 26 citations · Full text

Life Sciences, Hematology, Oncology +17

Merkel cell carcinoma expresses K homology domain–containing protein overexpressed in cancer similar to other high-grade neuroendocrine carcinomas

Jennifer G. Pryor, Rochelle A. Simon, Patricia Bourne et al. · Human Pathology · 2008 · 24 citations · Full text

Medicine, Molecular Biology, Oncology +12